Suppr超能文献

慢性丙咪嗪治疗后大鼠脑α1-肾上腺素能受体结合及肌醇磷脂代谢周转激活的评估。

Assessment of rat brain alpha 1-adrenoceptor binding and activation of inositol phospholipid turnover following chronic imipramine treatment.

作者信息

Li P P, Warsh J J, Sibony D, Chiu A

机构信息

Section of Biochemical Psychiatry, Clarke Institute of Psychiatry, Toronto, Ontario, Canada.

出版信息

Neurochem Res. 1988 Dec;13(12):1111-8. doi: 10.1007/BF00971627.

Abstract

Chronic (21 days) treatment of rats with imipramine (10 mg/kg) did not change the density or affinity of alpha 1-adrenoceptors as measured by the specific binding of [3H]prazosin in rat cortical membranes, but produced the expected significant decrease in the density of beta-adrenoceptors labeled by [125I]iodocyanopindolol. The functional status of brain alpha 1-adrenoceptors was also assessed by measuring the noradrenaline (NA)-induced accumulation of [3H]inositol 1-phosphate (IP1) in brain slices from these animals. No apparent change was observed in the concentration-response relationship between NA and [3H]IP1 accumulation in rat cerebral cortex after chronic treatment with imipramine. At concentrations higher than 1 microM in vitro, imipramine and its metabolite, desipramine, produced a concentration-dependent decrease in the [3H]IP1 accumulation elicited by NA. This inhibitory effect is likely mediated by direct blockade of alpha 1-adrenoceptors by these drugs. As the endogenous drug concentration would not reach 1 microM in our preparation, the lack of changes in alpha 1-adrenoceptor response following chronic imipramine treatment are not likely attributable to residual imipramine or desipramine retained in the tissues. In conclusion, the above findings do not support previous suggestions that brain alpha 1-adrenoceptors are upregulated following chronic imipramine administration.

摘要

用丙咪嗪(10毫克/千克)对大鼠进行慢性(21天)治疗,并未改变大鼠皮质膜中通过[3H]哌唑嗪特异性结合所测定的α1 - 肾上腺素能受体的密度或亲和力,但却使由[125I]碘氰吲哚洛尔标记的β - 肾上腺素能受体密度出现预期的显著下降。还通过测量这些动物脑片中去甲肾上腺素(NA)诱导的[3H]肌醇1 - 磷酸(IP1)积累,来评估脑α1 - 肾上腺素能受体的功能状态。在用丙咪嗪进行慢性治疗后,大鼠大脑皮质中NA与[3H]IP1积累之间的浓度 - 反应关系未观察到明显变化。在体外浓度高于1微摩尔时,丙咪嗪及其代谢产物地昔帕明会使NA引发的[3H]IP1积累呈浓度依赖性下降。这种抑制作用可能是由这些药物直接阻断α1 - 肾上腺素能受体介导的。由于在我们的实验制剂中内源性药物浓度不会达到1微摩尔,慢性丙咪嗪治疗后α1 - 肾上腺素能受体反应缺乏变化不太可能归因于组织中残留的丙咪嗪或地昔帕明。总之,上述发现不支持先前关于慢性给予丙咪嗪后脑α1 - 肾上腺素能受体会上调的观点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验